Pyxis Oncology Inc. (PYXS)
Pyxis Oncology Statistics
Share Statistics
Pyxis Oncology has 61.95M shares outstanding. The number of shares has increased by 4.59% in one year.
| 61.95M |
| 4.59% |
| 3.57% |
| 51.94% |
| n/a |
| 5,281 |
| 1.09% |
Short Selling Information
The latest short interest is 7.05M, so 11.38% of the outstanding shares have been sold short.
| 7.05M |
| 11.38% |
| 13.77% |
| 13.52 |
Valuation Ratios
The PE ratio is -1.18 and the forward PE ratio is -1.06. Pyxis Oncology's PEG ratio is 0.04.
| -1.18 |
| -1.06 |
| 5.65 |
| 1.1 |
| 0.76 |
| -1.57 |
| 0.04 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Pyxis Oncology.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 7.49, with a Debt / Equity ratio of 0.17.
| 7.49 |
| 7.49 |
| 0.17 |
| -0.31 |
| -0.35 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $366,954.55 |
| $-1,757,522.73 |
| 44 |
| 0.1 |
| n/a |
Taxes
| -2.16M |
| 2.72% |
Stock Price Statistics
The stock price has increased by -64.97% in the last 52 weeks. The beta is 1.18, so Pyxis Oncology's price volatility has been higher than the market average.
| 1.18 |
| -64.97% |
| 1.09 |
| 2.12 |
| 54.77 |
| 486,319 |
Income Statement
In the last 12 months, Pyxis Oncology had revenue of 16.15M and earned -77.33M in profits. Earnings per share was -1.32.
| 16.15M |
| 15.67M |
| -89.46M |
| -77.33M |
| -65.51M |
| -68.5M |
| -1.32 |
Balance Sheet
The company has 19.47M in cash and 20.2M in debt, giving a net cash position of -727K.
| 19.47M |
| 20.2M |
| -727K |
| -363.56M |
| 135.87M |
| 97.44M |
Cash Flow
In the last 12 months, operating cash flow was -57.67M and capital expenditures -237K, giving a free cash flow of -57.91M.
| -57.67M |
| -237K |
| -57.91M |
| -0.99 |
Margins
Gross margin is 97.06%, with operating and profit margins of -554.07% and -478.95%.
| 97.06% |
| -554.07% |
| -492.35% |
| -478.95% |
| -405.76% |
| -554.07% |
| -358.66% |
Dividends & Yields
PYXS does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for PYXS is $9, which is 625.8% higher than the current price. The consensus rating is "Buy".
| $9 |
| 625.8% |
| Buy |
| 5 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| -3.76 |
| 1 |